Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: CNS Pharma(CNSP) predict that the Revenue is 0 (--%), Meet estimate;the EBIT is -4.975 M (--%), Miss estimate;the EPS is -7.3 (+61.5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITMiss expectations
-0.00B--
-0.00B--
-0.00B--%
EPSMiss expectations
-7.361.50%
-5.3771.68%
-1.930010.18%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf